167 related articles for article (PubMed ID: 9824138)
1. Concurrent emergence of hepatitis B e antigen-negative hepatitis B virus variant and autoimmune hepatitis cured by adenine arabinoside monophosphate.
Bécheur H; Valla D; Loriot MA; Attar A; Bloch F; Petite JP
Dig Dis Sci; 1998 Nov; 43(11):2479-82. PubMed ID: 9824138
[TBL] [Abstract][Full Text] [Related]
2. A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.
Lok AS; Novick DM; Karayiannis P; Dunk AA; Sherlock S; Thomas HC
Hepatology; 1985; 5(6):1132-8. PubMed ID: 2415436
[TBL] [Abstract][Full Text] [Related]
3. Adenine arabinoside 5'-monophosphate treatment of chronic type B hepatitis.
Hoofnagle JH; Minuk GY; Dusheiko GM; Schafer DF; Johnson R; Straus S; Jones EA; Gerin JL; Ishak K
Hepatology; 1982; 2(6):784-8. PubMed ID: 6183183
[TBL] [Abstract][Full Text] [Related]
4. Chronic hepatitis B in children and adolescents.
Paganelli M; Stephenne X; Sokal EM
J Hepatol; 2012 Oct; 57(4):885-96. PubMed ID: 22634122
[No Abstract] [Full Text] [Related]
5. Adenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replication.
Marcellin P; Pouteau M; Loriot MA; Boyer N; Degos F; Calès P; Bettan L; Bacq Y; Coppére H; Grange JD
Gut; 1995 Mar; 36(3):422-6. PubMed ID: 7535285
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients.
Marcellin P; Ouzan D; Degos F; Brechot C; Metman EH; Degott C; Chevalier M; Berthelot P; Trepo C; Benhamou JP
Hepatology; 1989 Sep; 10(3):328-31. PubMed ID: 2474480
[TBL] [Abstract][Full Text] [Related]
7. Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial.
Bahrami H; Daryani NE; Haghpanah B; Moayyeri A; Moghadam KF; Mirmomen S; Kamangar F
Am J Gastroenterol; 2005 Apr; 100(4):856-61. PubMed ID: 15784032
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of woodchuck hepatitis virus replication by adenine arabinoside monophosphate coupled to lactosaminated poly-L-lysine and administered by intramuscular route.
Fiume L; Di Stefano G; Busi C; Mattioli A; Rapicetta M; Giuseppetti R; Ciccaglione AR; Argentini C
Hepatology; 1995 Oct; 22(4 Pt 1):1072-7. PubMed ID: 7557853
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.
Hoofnagle JH; Hanson RG; Minuk GY; Pappas SC; Schafer DF; Dusheiko GM; Straus SE; Popper H; Jones EA
Gastroenterology; 1984 Jan; 86(1):150-7. PubMed ID: 6196251
[TBL] [Abstract][Full Text] [Related]
10. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection.
Chu CJ; Hussain M; Lok AS
Hepatology; 2002 Dec; 36(6):1408-15. PubMed ID: 12447866
[TBL] [Abstract][Full Text] [Related]
11. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.
Chan HL; Chan CK; Hui AJ; Chan S; Poordad F; Chang TT; Mathurin P; Flaherty JF; Lin L; Corsa A; Gaggar A; Subramanian GM; McHutchison JG; Lau G; Lee S; Gane EJ
Gastroenterology; 2014 May; 146(5):1240-8. PubMed ID: 24462735
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.
Park H; Lee JM; Seo JH; Kim HS; Ahn SH; Kim DY; Han KH; Chon CY; Park JY
Liver Int; 2012 May; 32(5):796-802. PubMed ID: 22128792
[TBL] [Abstract][Full Text] [Related]
13. Antiviral Activity, Safety, and Pharmacokinetics of Capsid Assembly Modulator NVR 3-778 in Patients with Chronic HBV Infection.
Yuen MF; Gane EJ; Kim DJ; Weilert F; Yuen Chan HL; Lalezari J; Hwang SG; Nguyen T; Flores O; Hartman G; Liaw S; Lenz O; Kakuda TN; Talloen W; Schwabe C; Klumpp K; Brown N
Gastroenterology; 2019 Apr; 156(5):1392-1403.e7. PubMed ID: 30625297
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of hepatitis B surface antigen disappearance from and reappearance in the serum of patients with chronic HBV infection].
Hayashi J; Furusyo N; Nakamuta M; Shimada M
Nihon Rinsho; 2004 Aug; 62 Suppl 8():106-11. PubMed ID: 15453296
[No Abstract] [Full Text] [Related]
15. Efficacy of telbivudine treatment for hepatitis B e antigen-positive chronic hepatitis B patients with poor response to adefovir dipivoxil.
Li Y; Zhang Y; Wang JP; Lian JQ; Bai XF
J Viral Hepat; 2013 Apr; 20 Suppl 1():46-51. PubMed ID: 23458524
[TBL] [Abstract][Full Text] [Related]
16. [Interferon therapy for chronic hepatitis B].
Tang WL; Xie Q
Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):726-9. PubMed ID: 19874685
[No Abstract] [Full Text] [Related]
17. [Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].
Xu Y; Wang JB; Xu J; Jiao J; Zhang YG; Ji SW; Zhao P; Guo HH; Li Y; Zhou CY
Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):109-12. PubMed ID: 20196949
[TBL] [Abstract][Full Text] [Related]
18. [Treatment and selection criteria for chronic hepatitis B].
Gunji T; Omata M
Nihon Rinsho; 2004 Aug; 62 Suppl 8():309-12. PubMed ID: 15453336
[No Abstract] [Full Text] [Related]
19. Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir.
Hadziyannis SJ; Sevastianos V; Rapti I; Vassilopoulos D; Hadziyannis E
Gastroenterology; 2012 Sep; 143(3):629-636.e1. PubMed ID: 22659218
[TBL] [Abstract][Full Text] [Related]
20. [Interferon therapy for chronic hepatitis B].
Kakumu S
Nihon Rinsho; 2004 Aug; 62 Suppl 8():315-20. PubMed ID: 15453337
[No Abstract] [Full Text] [Related]
[Next] [New Search]